General Information of the Compound
Compound ID
CP0082813
Compound Name
1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea
    Show/Hide
Synonyms
1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea
1-isoquinolin-5-yl-3-[[4-(trifluoromethyl)phenyl]methyl]urea
A-425619
AC1OYT5J
LS-192912
T5512318
    Show/Hide
Structure
Formula
C18H14F3N3O
Molecular Weight
345.324
Canonical SMILES
FC(F)(F)c1ccc(CNC(=O)Nc2cccc3cnccc23)cc1
    Show/Hide
InChI
InChI=1S/C18H14F3N3O/c19-18(20,21)14-6-4-12(5-7-14)10-23-17(25)24-16-3-1-2-13-11-22-9-8-15(13)16/h1-9,11H,10H2,(H2,23,24,25)
    Show/Hide
InChIKey
SJGVXVZUSQLLJB-UHFFFAOYSA-N
Physicochemical Property
logP
4.5753
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
54.02
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 8068410
SID: 14952509
ChEMBL ID
CHEMBL104028
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
2
Ki = 5 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 4 nM
2 Ki = 18.3 nM
Clinical Information about the Compound
Drug 1 ( A-425619 )
Drug Name A-425619
Company Abbott
Indication
Pain
Preclinical
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Blocker